• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期质子泵抑制剂治疗继发的高胃泌素血症对人胃黏膜肠嗜铬样(ECL)细胞肿瘤发生的影响。

Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.

作者信息

Tatsuguchi Atsushi, Hoshino Shintaro, Kawami Noriyuki, Gudis Katya, Nomura Tsutomu, Shimizu Akira, Iwakiri Katsuhiko

机构信息

Department of Gastroenterology Nippon Medical School, Tokyo, Japan; Department of Analytic Human Pathology, Nippon Medical School, Graduate School of Medicine Tokyo, Japan.

Department of Gastroenterology Nippon Medical School, Tokyo, Japan.

出版信息

Pathol Res Pract. 2020 Oct;216(10):153113. doi: 10.1016/j.prp.2020.153113. Epub 2020 Jul 13.

DOI:10.1016/j.prp.2020.153113
PMID:32853950
Abstract

Proton pump inhibitor (PPI) therapy causes hypergastrinemia, which could promote the development and progression of neuroendocrine tumors (NETs). Concerns have been raised about the safety of long-term PPI use due to a possible increased risk of NETs. This study aimed to investigate the association between hypergastrinemia and the risk of NETs. Twenty outpatients presenting with serum gastrin levels greater than 400 pg/mL after long-term PPI treatment were registered in this study. Immunohistochemical analyses for chromogranin A (CgA), Ki67, gastrin and CCK/B gastrin receptor (CCKBR) were performed, and positive cell numbers were counted. There were no NET or gastric epithelial neoplasia cases observed among any of the 20 patients examined throughout the PPI treatment period. Histologically, ECL cell hyperplasia were shown in all patients. However, no relationship was found between serum gastrin levels and the number of CgA positive ECL cells. There was also no relationship between serum gastrin levels and the proportion of Ki67 positive cells or the density of CCKBR positive cells. The data indicate no relationship may exist between NETs and hypergastrinemia secondary to PPI treatment in patients having no, or mild, atrophic gastritis.

摘要

质子泵抑制剂(PPI)治疗会导致高胃泌素血症,这可能会促进神经内分泌肿瘤(NETs)的发生和发展。由于NETs风险可能增加,长期使用PPI的安全性受到了关注。本研究旨在调查高胃泌素血症与NETs风险之间的关联。本研究纳入了20例长期接受PPI治疗后血清胃泌素水平高于400 pg/mL的门诊患者。对嗜铬粒蛋白A(CgA)、Ki67、胃泌素和CCK/B胃泌素受体(CCKBR)进行免疫组织化学分析,并对阳性细胞数进行计数。在整个PPI治疗期间检查的20例患者中,未观察到NET或胃上皮肿瘤病例。组织学上,所有患者均显示肠嗜铬样(ECL)细胞增生。然而,血清胃泌素水平与CgA阳性ECL细胞数量之间未发现相关性。血清胃泌素水平与Ki67阳性细胞比例或CCKBR阳性细胞密度之间也没有相关性。数据表明,在无萎缩性胃炎或轻度萎缩性胃炎的患者中,NETs与PPI治疗继发的高胃泌素血症之间可能不存在关联。

相似文献

1
Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa.长期质子泵抑制剂治疗继发的高胃泌素血症对人胃黏膜肠嗜铬样(ECL)细胞肿瘤发生的影响。
Pathol Res Pract. 2020 Oct;216(10):153113. doi: 10.1016/j.prp.2020.153113. Epub 2020 Jul 13.
2
Proton Pump Inhibitor Use, Hypergastrinemia, and Gastric Carcinoids-What Is the Relationship?质子泵抑制剂的应用、高胃泌素血症与胃类癌——它们之间存在何种关联?
Int J Mol Sci. 2020 Jan 19;21(2):662. doi: 10.3390/ijms21020662.
3
Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.系统评价:长期质子泵抑制剂使用对血清胃泌素水平和胃组织学的影响。
Aliment Pharmacol Ther. 2015 Sep;42(6):649-63. doi: 10.1111/apt.13324. Epub 2015 Jul 16.
4
Gastric carcinoids after long-term use of a proton pump inhibitor.长期使用质子泵抑制剂后发生的胃类癌。
Aliment Pharmacol Ther. 2012 Oct;36(7):644-9. doi: 10.1111/apt.12012. Epub 2012 Aug 5.
5
Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.奈妥匹肽,一种胃泌素受体拮抗剂,在一项针对慢性萎缩性胃炎患者的非随机试验中,可使肿瘤标志物正常化,并使 1 型胃神经内分泌肿瘤消退。
PLoS One. 2013 Oct 1;8(10):e76462. doi: 10.1371/journal.pone.0076462. eCollection 2013.
6
Hypergastrinemia Expands Gastric ECL Cells Through CCK2R Progenitor Cells via ERK Activation.高胃泌素血症通过 ERK 激活 CCK2R 祖细胞扩大胃 EC 细胞。
Cell Mol Gastroenterol Hepatol. 2020;10(2):434-449.e1. doi: 10.1016/j.jcmgh.2020.04.008. Epub 2020 Apr 21.
7
The gastric mucosa 25 years after proximal gastric vagotomy.近端胃迷走神经切断术后25年的胃黏膜情况
Scand J Gastroenterol. 2014 Oct;49(10):1173-80. doi: 10.3109/00365521.2014.950979. Epub 2014 Aug 26.
8
A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.进餐试验可提高嗜铬粒蛋白A作为神经内分泌肿瘤标志物的特异性。
Tumour Biol. 2010 Oct;31(5):373-80. doi: 10.1007/s13277-010-0045-5. Epub 2010 May 18.
9
Gastric neuroendocrine tumours from long-term proton pump inhibitor users are indolent tumours with good prognosis.长期使用质子泵抑制剂的患者发生的胃神经内分泌肿瘤为惰性肿瘤,预后良好。
Histopathology. 2020 Dec;77(6):865-876. doi: 10.1111/his.14220. Epub 2020 Sep 20.
10
Old and New Gut Hormone, Gastrin and Acid Suppressive Therapy.新旧肠激素,胃泌素和抑酸治疗。
Digestion. 2018;97(4):340-344. doi: 10.1159/000485734. Epub 2018 Mar 27.

引用本文的文献

1
A Systematic Review of the Adverse Effects of Long-Term Proton Pump Inhibitor Use on the Gastrointestinal System in the Adult Population.长期使用质子泵抑制剂对成年人群胃肠道系统不良反应的系统评价
Cureus. 2025 Aug 20;17(8):e90606. doi: 10.7759/cureus.90606. eCollection 2025 Aug.
2
Endoscopic findings and outcomes of gastric mucosal changes relating to potassium-competitive acid blocker and proton pump inhibitor therapy.与钾离子竞争性酸阻滞剂和质子泵抑制剂治疗相关的胃黏膜变化的内镜检查结果及转归
DEN Open. 2024 Jun 24;5(1):e400. doi: 10.1002/deo2.400. eCollection 2025 Apr.
3
Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials.
质子泵抑制剂用于小儿胃食管反流病:随机对照试验的系统评价
Children (Basel). 2024 Mar 1;11(3):296. doi: 10.3390/children11030296.